Lucia Altucci is Associate Professor of General Pathology at University of Naples 2, Department of Biochemistry, Biophysics and general Pathology, where she is teaches the causal mechanisms of diseases with a focus on tumorigenesis to medical students, technicians and biotechnologists.
She is member of the Translational Medicine Ph.D. scientific board. She has also been appointed as associate researcher at IGB-CNR, where she holds a research laboratory. She teaches mechanisms of diseases in several programs of specialization schools and masters. She is member of the governing board of the University of Naples 2 where she is part of the Research Commission and of the board assuring the quality of the Research.
Since 2014 she is collaborating with AVA and ANVUR taking part to the evaluating committee of Research centers, Universities and quality of researchers. She is Editor of the IJBCB (Elsevier) and of J Clinical Epigenetics (Biomed Central). She is part of many International committees for the evaluation of research in EU and outside.
Altucci’s research has been granted with International funds such as FP5, FP6, FP7 and H2020 EU programs, AICR etc.
Lucia won the Presidential gold medal for her studies on Epigenetics & Cancer in 2010 and the price for cancer research given from the prestigious ‘Accademia dei Lincei’ in 2005.
Her research focuses on innovative therapeutic strategies against cancer, (epi)drug discovery and development, identification of pathogenesis of diseases with a focus on cancer (epi)genome alterations.
She is author of a large number of publications (more than 160) on these topics. The full list can be found at http://www.ncbi.nlm.nih.gov/pubmed/?term=altucci+l
She is one of the founding members of the companies Mesogenics and Epi-C.v